Future topics IMI2 Call 17 for proposals

The Innovative Medicines Initiative (IMI) has published three topics that are under consideration for inclusion in the seventeenth call for proposals. The topics are now at an advanced stage of development and IMI hopes that these drafts will allow potential applicants to start working actively on proposals and forming consortia.

The topics under consideration are the following:

• Optimising future obesity treatment;
• Open access chemogenomics library and chemical probes for the druggable genome;
• Intelligent prediction and identification of environmental risks posed by human medicinal products.

All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board.

The goal of the IMI 2 is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.